Abbott Laboratories SEC filings, summarized
We read every Abbott Laboratories 8-K filing and insider trade the night it hits SEC EDGAR, and turn it into a two-minute plain-English summary.
Track ABT in your inbox
Add Abbott Laboratories to your watchlist — free, every morning.
Recent filings
Abbott (via Badger Merger Sub I) has an Agreement & Plan of Merger with Exact Sciences dated Nov 19, 2025…
Abbott (via Badger Merger Sub I) has an Agreement & Plan of Merger with Exact Sciences dated Nov 19, 2025 incorporated by reference in an 8‑K filed Mar 23,…
Abbott ($ABT) closed its acquisition of Exact Sciences ($EXAS) on Mar 23, 2026.
Abbott ($ABT) closed its acquisition of Exact Sciences ($EXAS) on Mar 23, 2026. Merger Sub merged into Exact; Exact is now a direct, wholly owned subsidiary…
Abbott filed an 8‑K (Item 9.01) on Mar 9, 2026 furnishing an indenture and note forms for debt: Floating…
Abbott filed an 8‑K (Item 9.01) on Mar 9, 2026 furnishing an indenture and note forms for debt: Floating Rate due 2029; 3.70% (2029); 4.00% (2031); 4.30%…
Abbott Labs 8‑K filed 2026‑03‑09: Item 2.03 simply incorporates Item 1.01 by reference — it does not…
Abbott Labs 8‑K filed 2026‑03‑09: Item 2.03 simply incorporates Item 1.01 by reference — it does not itself create any new direct financial obligation or…
BREAKING: Abbott completes $20B senior notes offering to fund the Exact Sciences takeover — $ABT $EXAS…
BREAKING: Abbott completes $20B senior notes offering to fund the Exact Sciences takeover — $ABT $EXAS 🚨💰 #BREAKING #Mergers #Biotech #FinTwit ALERT:…
Abbott ($ABT) filed an 8-K on Feb 26, 2026 — added Exhibit 1.1 (Pricing Agreement) and XBRL cover page.
Abbott ($ABT) filed an 8-K on Feb 26, 2026 — added Exhibit 1.1 (Pricing Agreement) and XBRL cover page. Disclosure points to an expected closing of a Notes…
BREAKING: $ABT confirms a $20B senior notes offering to fund the Exact Sciences acquisition 🚨💵 Pricing…
BREAKING: $ABT confirms a $20B senior notes offering to fund the Exact Sciences acquisition 🚨💵 Pricing agreement signed with Morgan Stanley, Barclays,…
Abbott Laboratories filed an 8‑K (Item 9.01) on Jan 22, 2026 — furnished a press release (Exhibit 99.1)…
Abbott Laboratories filed an 8‑K (Item 9.01) on Jan 22, 2026 — furnished a press release (Exhibit 99.1) and an Inline XBRL cover page (Exhibit 104). Review…
Abbott filed Q4 & FY2025 results on Jan 22, 2026 (Exhibit 99.1).
Abbott filed Q4 & FY2025 results on Jan 22, 2026 (Exhibit 99.1). The release emphasizes non‑GAAP "net earnings excluding specified items" to show underlying…